Medical Book

See Also

Humanitarian People


Tuesday 6th of January 2009

Human Growth Hormone > Nutropin > South San Francisco

Please select a HGH news story from the list below:

Biotech Equipment Update - FDA APPROVES NUTROPIN AQ PEN FOR DELIVERY OF GROWTH HORMONE.(Genetech Inc.)

Saturday 1st of June 2002

June 1, 2002 -- Genentech, Inc. (NYSE:DNA), South San Francisco, has announced that the Nutropin AQ Pen(TM) has received clearance from the FDA. The Nutropin AQ...

Business Wire - Schwarz Pharma's Rights to Growth Hormone Products Reacquired by Genentech; Schwarz Pharma to Focus on Central Nervous System and Urology

Friday 8th of June 2001

June 8, 2001 -- Business Editors SOUTH SAN FRANCISCO, Calif. & MONHEIM, Germany--(BUSINESS WIRE)-- June 7, 2001 Schwarz Pharma AG and Genentech, Inc. announced...

Business Wire - Genentech Corrects and Replaces Previous Genentech and Alkermes Announcment, BW0172 CA-GENENTECH/ALKERMES

Monday 8th of January 2001

January 8, 2001 -- Business Editors NOTE: The following news release replaces and corrects the previous Genentech news release, which ran earlier Monday on...

M2 Presswire - Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available.

Thursday 29th of June 2000

June 29, 2000 -- M2 PRESSWIRE-29 June 2000-GENENTECH: Nutropin Depot, first long-acting dosage form of recombinant growth hormone, now available (C)1994-2000 M2...

Business Wire - Nutropin Depot, First Long-Acting Dosage Form of Recombinant Growth Hormone, Now Available

Wednesday 28th of June 2000

June 28, 2000 -- Business Editors and Health/Medical Writers SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass.--(BW HealthWire)--June 28, 2000--Genentech, Inc....

Family Pratice News - Long-Acting Growth Hormone - Statistical Data Included - Brief Article

Thursday 1st of June 2000

June 1, 2000 -- Nutropin Depot (somatropin [rDNA origin] for injection), the first long-acting dosage form of recombinant growth hormone, is indicated for treating...

M2 Presswire - US FDA: FDA approves Nutropin Depot, first lo long-acting dosage form of recombinant growth hormone.

Friday 24th of December 1999

December 24, 1999 -- M2 PRESSWIRE-24 December 1999-US FDA: FDA approves Nutropin Depot, first long-acting dosage form of recombinant growth hormone for growth hormone...

M2 Presswire - GENENTECH: FDA approves results for spine bone mi mineral density in childhood-onset GHD adults.

Friday 3rd of December 1999

December 3, 1999 -- M2 PRESSWIRE-3 December 1999-GENENTECH: FDA approves efficacy results for spine bone mineral density in childhood-onset growth hormone deficient...

M2 Presswire - GENENTECH: Genentech & Alkermes announce submission of drug application with the FDA for Nutropin Depot.

Tuesday 29th of June 1999

June 29, 1999 -- M2 PRESSWIRE-29 June 1999-GENENTECH: Genentech and Alkermes announce the submission of a new drug application with the FDA for Nutropin Depot...

Business Wire - Phase III Clinical Trial Shows Promising Results of Nutropin Depot; First Long-Acting Formulation of Recombinant Growth Hormone

Monday 14th of June 1999

June 14, 1999 -- SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass.--(BW HealthWire) --June 13, 1999-- Genentech, Inc. (NYSE:GNE) and Alkermes, Inc. (Nasdaq:ALKS)...

Cities

Province/States

Country

Company


About

Our goal is to spread human growth hormone information in the form of general information and useful HGH articles from a wide variety of print publications.


Add a Bookmark

If we've proved to be a useful resource why not now?


designed: expert answers